bioAffinity Technologies (BIAF) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for bioAffinity Technologies
Is bioAffinity Technologies a buy right now? The alternative data says hold. This BIAF stock analysis is built on the 25+ alternative data signals AltIndex tracks on bioAffinity Technologies every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 55/100: a Hold. The stock trades at $9.39 with a $5M market cap.
The soft spots over the past 90 days: sentiment down 12.0% to 88/100. The rest of the signal set is holding steady, which keeps BIAF at a hold rather than a sell.
BIAF’s broader alt-data profile also covers headcount (34 employees, according to LinkedIn), web traffic (5K monthly visits), and X followers (296). Every signal links to its own page with full history, the BIAF technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on BIAF is just below.
bioAffinity Technologies AI Stock Analysis
BioAffinity Technologies is a biomedical company focused on developing and commercializing proprietary technologies to diagnose and treat diseases at the cellular level. The company leverages innovative approaches in the detection and treatment of cancer, enhancing patient outcomes through specialized diagnostic tests and therapeutic methods.
Analysis generated August 29, 2026.
Recent bioAffinity Technologies Stock Alerts
|
bioAffinity Technologies | September 10 Price is down by -8.6% in the last 24h. |
|
bioAffinity Technologies | September 9 Price is up by 21.8% in the last 24h. |
|
bioAffinity Technologies | September 8 Price is down by -36.7% in the last 24h. |
|
bioAffinity Technologies | September 4 Price is down by -13.9% in the last 24h. |
bioAffinity Technologies Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 5K | N/A | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 34 | N/A | |
| Sentiment | 88 | 12.0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 2 | N/A | |
| Stocktwits Mentions | 1K | 40,800.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 4K | N/A | |
| X Followers | 296 | N/A |
About bioAffinity Technologies (BIAF)
bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer. The company is headquartered in San Antonio, Texas.
| Price | $9.39 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $5M |
| Year Range | $5 – $158 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Health Care Services |
Latest bioAffinity Technologies News
View more → |
WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq RulesAugust 14 - PRNewswire |
 |
bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right?September 4 - Biztoc.com |
See bioAffinity Technologies’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for BIAF, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEbioAffinity Technologies Earnings & Financial Performance
View all earnings →bioAffinity Technologies Insider Trading Activity
View all →| No recent insider transactions on file. |
bioAffinity Technologies Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to bioAffinity Technologies
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Hong Kong Pharma DigitalHKPD |
$0.12 5.9% | $6M | 48 |
 |
Inspire Veterinary PartnersIVP |
$0.03 16.1% | $4M | 48 |
 |
iSpecimenISPC |
$1.50 3.2% | $4M | 38 |
 |
XWELLXWEL |
$0.94 1.3% | $8M | 46 |
 |
NewGenIvf GroupNIVF |
$1.11 0.9% | $2M | 48 |
Explore bioAffinity Technologies Data
Frequently Asked Questions: bioAffinity Technologies (BIAF)
bioAffinity Technologies has an AltIndex AI Score of 55/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
55/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of bioAffinity Technologies (BIAF) stock is $9.39 with a market cap of $5M.
As of today, bioAffinity Technologies’s PE (Price to Earnings) ratio is —.
View the latest bioAffinity Technologies insider transactions to see recent buying and selling activity by company executives and directors.
Check the bioAffinity Technologies congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The BIAF stock price chart above shows bioAffinity Technologies’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full bioAffinity Technologies technical analysis for RSI, moving averages, and more.
See the stocks similar to bioAffinity Technologies section on this page for companies in the same industry ranked by market cap and AI Score.
